Lipoprotein-Associated Phospholipase A ₂ and Cardiovascular Risk

This publication has 15 references indexed in Scilit:

• Lipoprotein-Associated Phospholipase A ₂ Is an Independent Marker for Coronary Endothelial Dysfunction in Humans
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
• The effect of statin therapy on lipoprotein associated phospholipase A2 levels
  Atherosclerosis, 2005
• Effects of Atorvastatin Versus Other Statins on Fasting and Postprandial C-Reactive Protein and Lipoprotein-Associated Phospholipase A2 in Patients With Coronary Heart Disease Versus Control Subjects
  The American Journal of Cardiology, 2005
• Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke
  Circulation, 2005
• Association of Lipoprotein-Associated Phospholipase A ₂ Mass and Activity With Calcified Coronary Plaque in Young Adults
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
• Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up
  European Heart Journal, 2004
• Lipoprotein-Associated Phospholipase A ₂ Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population
  Circulation, 2004
• Lipoprotein-Associated Phospholipase A ₂ , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
  Circulation, 2004
• A prospective evaluation of lipoprotein-associated phospholipase A2levels and the risk of future cardiovascular events in women
  Journal of the American College of Cardiology, 2001
• Lipoprotein-Associated Phospholipase A₂as an Independent Predictor of Coronary Heart Disease
  New England Journal of Medicine, 2000